SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

 

Quarterly Report Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

FOR THE QUARTER ENDED MARCH 31, 2000

Commission file number 1-9330

 

INTELLIGENT SYSTEMS CORPORATION

(Exact name of Registrant as specified in its charter)

Georgia 58-1964787

(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)

4355 Shackleford Road, Norcross, Georgia 30093

(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code: (770) 381-2900

 

Indicate by a check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ___

As of March 31, 2000, 5,684,467 shares of Common Stock were outstanding.

 

Item 1. Financial Statements

Intelligent Systems Corporation

CONSOLIDATED BALANCE SHEETS

(in thousands except share amounts)

 

March 31,

2000

December 31,

1999

ASSETS

(Unaudited)

(Audited)

Current assets:

   

Cash

$ 8,007

$ 737

Accounts receivable, net

1,675

1,464

Notes and interest receivable

90

254

Inventories

426

325

Other current assets

303

263

Total current assets

10,501

3,043

Long-term investments

14,849

8,576

Long-term notes receivable

47

53

Property and equipment, at cost less accumulated depreciation and amortization

653

686

Other assets

1,300

1,300

Total assets

$27,350

$13,658

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

   

Current liabilities:

   

Short-term borrowings

$ 1,100

$ 1,000

Accounts payable

664

444

Accrued expenses and other current liabilities

4,661

1,647

Total current liabilities

6,425

3,091

Long-term debt

163

363

Minority interest

(2)

(5)

Stockholders’ equity:

   

Common stock, $.01 par value, 20,000,000 authorized, 5,684,467 and

   

5,114,467 outstanding at March 31, 2000 and December 31, 1999, respectively

57

51

Paid-in capital

24,062

24,069

Unrealized gain in available-for-sale securities

5,859

731

Cash dividend declared

(2,956)

--

Accumulated deficit

(6,258)

(14,642)

Total stockholders’ equity

20,764

10,209

Total liabilities and stockholders’ equity

$27,350

$13,658

The accompanying notes are an integral part of these balance sheets.

Intelligent Systems Corporation

CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited, in thousands except share amounts)

Three Months Ended March 31,

2000

1999

Net sales

$2,007

$2,683

Expenses:

   

Cost of sales

841

1,386

Marketing

220

376

General & administrative

1,047

1,030

Research & development

208

175

Loss from operations

(309)

(284)

Other income (expense):

   

Interest income (expense)

32

(38)

Investment income, net

8,653

1,417

Other income, net

11

1

Income before minority interest

8,387

1,096

Minority interest

3

2

Net income

$8,384

$1,094

Basic net income per share based upon basic weighted average shares

$1.48

$0.21

Diluted net income per share based upon diluted weighted average shares

$1.46

$0.21

Basic weighted average shares outstanding

5,653,822

5,104,467

Diluted weighted average shares outstanding

5,735,720

5,271,041

The accompanying notes are an integral part of these statements.

Intelligent Systems Corporation

CONSOLIDATED STATEMENTS OF CASH FLOW

(unaudited, in thousands)

 

Three Months Ended March 31,

CASH PROVIDED BY (USED FOR):

2000

1999

   

OPERATIONS:

   

Net income

$8,384

$1,094

Adjustments to reconcile net income to net cash used for operating activities, net of effects of acquisitions and dispositions:

   

Depreciation and amortization

21

78

Gain from sales of assets

(8,849)

(1,047)

Equity in net loss (income) of affiliates

195

(371)

Changes in operating assets and liabilities:

   

Accounts receivable

(211)

(42)

Inventories

(101)

(7)

Other current assets

(40)

142

Accounts payable

220

(378)

Accrued expenses and other current liabilities

58

38

Cash used for continuing operations

(323)

(493)

     

INVESTING ACTIVITIES:

   

Proceeds from sales of investments

8,938

1,187

Acquisitions of long-term investments

(1,400)

(200)

Increase in minority interest

3

2

Repayment (advances) under notes receivable, net

141

(15)

Dispositions of property and equipment, net

11

117

Cash provided by investing activities

7,693

1,091

     

FINANCING ACTIVITIES:

   

Net repayments under short-term borrowing arrangements

(100)

(210)

Foreign currency translation adjustment

--

94

Cash provided by (used for) financing activities

(100)

(116)

Net increase in cash

7,270

482

Cash at beginning of period

737

461

Cash at end of period

$8,007

$ 943

     

The accompanying notes are an integral part of these statements.

Intelligent Systems Corporation

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

  1. Throughout this report, the terms "we", "us", "ours", "ISC" and "company" refer to Intelligent Systems Corporation, including its subsidiaries.
  2. The unaudited consolidated financial statements presented in this Form 10-Q have been prepared in accordance with generally accepted accounting principles applicable to interim financial statements. Accordingly, they do not include all of the information and notes required by generally accepted accounting principles for complete financial statements. In the opinion of ISC management, these consolidated financial statements contain all adjustments (which comprise only normal and recurring accruals) necessary to present fairly the financial position as of March 31, 2000 and 1999. The interim results for the three months ended March 31, 2000 are not necessarily indicative of the results to be expected for the full year. These statements should be read in conjunction with our combined financial statements for the fiscal year ended December 31, 1999, as filed in our annual report on Form 10-K.
  3. Comprehensive Income - In June 1997, the Financial Accounting Standards Board issued Statement No. 130, "Reporting Comprehensive Income". The Statement requires companies to report comprehensive income and its components in their financial statements. Comprehensive income is the total of net income and all other non-owner changes in equity in a period. We adopted the disclosure requirements of this statement in March 1998.

Consolidated Statements of Comprehensive Income

(unaudited, in thousands)

 

Three Months Ended March 31,

 

2000

1999

Net Income

$ 8,384

$1,094

Other comprehensive income (loss):

   

Foreign currency translation adjustments

--

197

Unrealized gain (loss) in available-for-sale securities

5,127

(636)

Comprehensive income

$13,511

$ 655

  1. Sale of Interest in Risk Laboratories, LLC ("Risk") - In the quarter ended March 31, 2000, we sold 2,310,000 equity units in Risk for $8,801,000 in cash to American Home Assurance Company, recognizing a gain of $8,622,000 on the transaction. We retain ownership of 623,515 equity units representing approximately 7 percent of the equity of Risk, after a capital infusion of $5,000,000 in Risk by American Home Assurance Company.
  2. Sale of Partial Holdings in S1 Corporation - In the first quarter ended March 31, 2000, we sold 2,000 shares of common stock of S1 Corporation [NASDAQ: SONE] for $217,000 cash, recognizing a gain of $207,000. We retain ownership of 8,000 shares of S1 Corporation stock. The stock in S1 Corporation was received as consideration for our shares of stock in VerticalOne Corporation upon the merger of VerticalOne and S1 Corporation in the fourth quarter of 1999.

Item 2. Management's Discussion and Analysis of Results of Operations and Financial

Condition

Results of Operations

Summary - Our consolidated operating subsidiaries in 2000 are ChemFree Corporation, QS Technologies and PsyCare America. In the first quarter of 1999, we also consolidated the results of our InterQuad subsidiary prior to its sale in February 1999. Part of the difference in consolidated operating results between the first quarter last year and this year is a result of not including the InterQuad operation and its financial losses from the date of its sale in February 1999.

Overall, results for ongoing consolidated companies improved year-to-year, with each subsidiary operating profitably. During the current quarter we recognized a significant return on the sale of part of our investment in Risk Laboratories which resulted in net income for the quarter of $8.4 million compared to $1.1 million for the first quarter of 1999. Refer to Note 4 on page 5.

Sales - We generate revenue from operations in two industry segments: technology-related products and services, and health care services. For the three month period ended March 31, 2000, net sales were $2,007,000, a decline of 25 percent compared to the first